Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) announced that it has entered into an oncology clinical collaboration with Pfizer Inc. (NYSE: PFE) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
